cyc 202 has been researched along with DDD MPGNII in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellis, D; Chiara, M; Davit, A; De Rosa, G; Di Simone, D; Giachino, O; Menegatti, E; Roccatello, D; Sena, LM; Sferch, D | 1 |
Meijer, L; Pippin, JW; Qu, Q; Shankland, SJ | 1 |
2 other study(ies) available for cyc 202 and DDD MPGNII
Article | Year |
---|---|
Mycophenolate mofetil and roscovitine decrease cyclin expression and increase p27(kip1) expression in anti Thy1 mesangial proliferative nephritis.
Topics: Animals; Cell Cycle Proteins; Cyclin B; Cyclin D; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; Glomerular Mesangium; Glomerulonephritis, Membranoproliferative; Immunohistochemistry; In Situ Hybridization; Male; Models, Animal; Mycophenolic Acid; Purines; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Roscovitine; Th1 Cells; Tumor Suppressor Proteins | 2005 |
Direct in vivo inhibition of the nuclear cell cycle cascade in experimental mesangial proliferative glomerulonephritis with Roscovitine, a novel cyclin-dependent kinase antagonist.
Topics: Animals; CDC2-CDC28 Kinases; Cell Cycle; Cell Nucleus; Cells, Cultured; Collagen; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; Enzyme Inhibitors; Fibronectins; Glomerular Mesangium; Glomerulonephritis, Membranoproliferative; Kidney Function Tests; Laminin; Protein Kinases; Protein Serine-Threonine Kinases; Purines; Rats; Rats, Wistar; Roscovitine | 1997 |